Year in review 2022

A brief overview of some of the biggest events in The Neuro’s past 12 months

In 2022 life slowly returned to somewhat normal after two years of pandemic, yet challenges due to COVID-19 remain, especially for the health care system. Despite this, The Neuro’s health care workers, staff, students and faculty have made great strides in patient care and neurological disease research. Here are some of our top stories from 2022.

A Day in the Life

The Neuro continued its A Day in The Life series in 2022, following clinical staff and researchers as they went about their work. This year we followed

Remembering Richard Murphy

In 2022 The Neuro lost Richard Murphy, a former director who in the 1990s recruited a cadre of young molecular neuroscientists, establishing a strong and vibrant molecular and cellular research group. Their research would uncover the mechanisms of brain function and the underlying causes of neurological disorders. Murphy spearheaded the campaign to build the Brain Tumour Research Centre. He was known and highly regarded for his mentorship and as a strong advocate for the faculty, especially those early in their careers. He established an internal grant review process, encouraging colleagues to mentor and guide each other.

Royal Society Inductees

In September two Neuro faculty, Heidi McBride and Nathan Spreng, were inducted into The Royal Society of Canada (RSC), recognizing their contributions to our understanding of neuroscience and the human brain.

New Open Science partnership

Furthering The Neuro’s Tanenbaum Open Science Institute (TOSI) in its goal of promoting Open Science nationwide, the Douglas Research Centre in Montreal joined TOSI in a new OS partnership to share research data and collaborate through the adoption of a set of new institutional principles.

Long COVID study

Led by Dr. Lesley Fellows, the Quebec Action for Post-COVID (QAPC) study began recruiting men and women living in Quebec, aged 18 years and older who report the presence of symptoms that developed during or after their COVID-19 infection, lasting more than four weeks and that cannot be explained by another diagnosis.

New director for the Early Drug Discovery Unit (EDDU)

The EDDU got a new director in 2022. Tom Durcan will lead the EDDU team as it develops human induced pluripotent stem cells (iPSCs) to explore new targets for neurological disease treatments.

Autism voices across the spectrum

Researchers at McGill University reported in May their flexible interviewing protocol, called Autism Voices, with 33 participants pulled from the longitudinal Pathways in ASD study.

Expanding Parkinson’s study

A Parkinson’s study underway at the Clinical Research Unit expanded its patient cohort in May. The thinking behind the Parkinson’s Progression Markers Initiative from the Michael J. Fox Foundation is that by learning everything we can about how the disease develops and progresses, we can create better targeted therapies and, just as importantly, test them more accurately in clinical trials.

ALS collaboration

In 2022 the Clinical Research Unit became part of CAPTURE ALS (Comprehensive Analysis Platform To Understand, Remedy, and Eliminate ALS), a Canadian initiative that is developing the world’s most detailed and comprehensive picture of the disease. Data from across Canada for this Open Science initiative will be stored at The Neuro's C-BIG open biobank.

Extension to the appointment of Dr. Guy Rouleau as Director of The Neuro

Dr. Guy Rouleau received a three-year extension as Director of The Neuro effective Jan. 1, 2023, as approved by McGill University’s Board of Governors at its meeting of Feb. 10, 2022, and by the Board of Directors of the McGill University Health Centre (MUHC) at its public meeting of May 13, 2022.

New faces

The Neuro added many new faculty and staff throughout 2022. Here are some of them:

Udunna Anazodo joined The Neuro as an assistant professor in the Department of Neurology and Neurosurgery and a member of the Neuroimaging and Neuroinformatics Research Group.

Collin-Michael Antonio joined The Neuro as a nurse manager

Sabrina Burr became the new medical librarian, replacing Eileen Beany Peterson who retired after 22 years serving our patients with helpful medical information.

Justine Cléry became an assistant professor in the Department of Neurology and Neurosurgery and a member of the Neurodevelopmental Disorders Research Group and the Azrieli Centre for Autism Research.

Adil Harroud became an assistant professor in the Department of Neurology and Neurosurgery and a member of the Neuroimmunological Diseases Research Group

Massimo Pandolfo joined the Clinical Research Unit as a co-director

Pedro Rosa-Neto became a member of the Neuroimaging and Neuroinformatics Research Group and the McConnell Brain Imaging Centre.

Wendy Sculnick became Managing Director of Philanthropy

Lisa Volume became Associate Director of the Centre for Neurological Disease Models

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

FacebookinstagramtwitterlinkedInyoutube

Back to top